Literature DB >> 8684870

Randomized, double blind comparison of brand and generic antibiotic suspensions: I. A study of taste in adults.

K M Samulak1, G M El-Chaar, L G Rubin.   

Abstract

BACKGROUND: A belief that brand oral liquid medications taste better than their generic counterparts may influence prescribing habits among pediatricians.
METHODS: We undertook a prospective, randomized, double blinded, comparative evaluation of the taste of brand and generic erythromycin ethylsuccinate, cephalexin monohydrate, erythromycin ethylsuccinate/sulfisoxazole, penicillin V potassium and trimethoprim-sulfamethoxazole in 42 adult volunteers. Subjects tasted one class of brand and generic antibiotics and rated them according to smell, texture, taste and aftertaste.
RESULTS: At least one generic preparation of cephalexin, erythromycin ethylsuccinate/sulfisoxazole and penicillin V potassium was rated equal in taste to the respective brand name products. However, brand erythromycin estolate and trimethoprim-sulfamethoxazole name brand suspensions rated significantly higher than the other products tested.
CONCLUSIONS: Based on our results brand name oral antibiotic formulations do not necessarily taste better than their generic counterparts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684870     DOI: 10.1097/00006454-199601000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

1.  Stability, dose uniformity, and palatability of three counterterrorism drugs-human subject and electronic tongue studies.

Authors:  Nakissa Sadrieh; James Brower; Lawrence Yu; William Doub; Arthur Straughn; Stella Machado; Frank Pelsor; Emmanuelle Saint Martin; Terry Moore; John Reepmeyer; Duckhee Toler; Agnes Nguyenpho; Rosemary Roberts; Donald J Schuirmann; Moheb Nasr; Lucinda Buhse
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

2.  Palatability of liquid anti-infectives: clinician and student perceptions and practice outcomes.

Authors:  Stacy C Gee; Tracy M Hagemann
Journal:  J Pediatr Pharmacol Ther       Date:  2007-10

Review 3.  Practical considerations when treating children with antimicrobials in the outpatient setting.

Authors:  L N Werk; H Bauchner
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.